财联社3月24日电,减肥药概念快速拉升,美诺华3天2板,金凯生科涨超10%,科兴制药、泰恩康、阳光诺和跟涨。消息面上,诺和诺德司美格鲁肽在中国的核心化合物专利到期。这意味着,这款被称为“全球药王”的单品,长期垄断格局就此打破。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.